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Purpose: Estimate the association between dietary intake of cadmium, a carcinogenic heavy 
metal, and risk of invasive breast cancer.  
Methods: Study subjects were 30,543 postmenopausal women in the VITamins And Lifestyle 
(VITAL) cohort who completed a food frequency questionnaire (FFQ) at baseline (2000-2002). 
Dietary cadmium consumption was estimated by combining FFQ responses with US Food and 
Drug Administration data on food cadmium content. Incidence of invasive breast cancer was 
ascertained through linkage of the cohort to the western Washington Surveillance, 
Epidemiology, and End Results cancer registry through December 31, 2009. Cox regression 
was applied to estimate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for 
breast cancer with increasing dietary cadmium intake, adjusted for total energy intake, smoking 
history, consumption of vegetables, potatoes, and whole grains, multivitamin use, education, 
race, body mass index, physical activity, age at first birth, postmenopausal hormone use, and 
mammography.  
Results: Vegetables and grains together contributed an average of 66% of estimated dietary 
cadmium. During a mean of 7.5 years of follow-up, 1,026 invasive postmenopausal breast 
cancers were identified. Among 899 cases with complete covariate information, no evidence of 
an association between dietary cadmium intake and breast cancer risk was observed (aHR 
(95% CI), highest to lowest quartile cadmium: 1.00 (0.72-1.41), Ptrend=0.95). No evidence was 
found for interactions between dietary cadmium and breast cancer risk factors, smoking habits, 
or total intake of calcium, iron, or zinc from diet, supplements, and multivitamins.  
Conclusions: This study does not support the hypothesis that dietary cadmium intake is a risk 
factor for breast cancer. However, non-differential measurement error in the estimate of 
cadmium intake is likely the most important factor that could have obscured an association.  
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Cadmium is a toxic and carcinogenic heavy metal released into the environment as a result of 
industrial and agricultural activities[1, 2]. Historically, most research on the health effects of 
cadmium has focused on occupational exposure[3]. However, chronic non-occupational 
exposure to cadmium is common. Cadmium is taken up from contaminated soil by tobacco, 
grains, and a variety of vegetables[4-7]. Cadmium inhaled with cigarette smoke is readily 
absorbed by lung tissue[8]. Although only approximately 5% of cadmium ingested in food is 
absorbed, cadmium absorption is potentiated by low iron stores, and it may be in part for this 
reason that women are consistently observed to have higher average urine and blood cadmium 
concentrations[9, 10]. Cadmium, once absorbed from the environment, is retained throughout 
the body, including in breast tissue for decades[8, 11-13].  
Multiple mechanisms potentially link cadmium to carcinogenesis including oxidative stress and 
inflammation[14, 15], interference with DNA repair[16, 17], and alterations of DNA 
methylation[18]. Intriguing laboratory evidence suggests that cadmium may act on estrogenic 
signaling pathways[19, 20], stimulating proliferation of breast cancer cells in culture[21], and 
inducing increased uterus and mammary gland weight in rats[22]. Further evidence specifically 
shows that low level, long term cadmium can malignantly transform breast cells, albeit through 
pathways independent of estrogen receptor(α)[23]. 
Cadmium has been linked to lung cancer in occupational settings[24, 25], although uncertainty 
remains[26]. In non-occupationally exposed populations, cadmium has also been associated 
with lung cancer incidence and mortality[27, 28]. Because of the laboratory data potentially 
linking cadmium with estrogen signaling pathways, cadmium has received increasing attention 
as a risk factor for hormone-related cancers in women. Prospective studies in Sweden observed 
an association between dietary cadmium and risk of breast cancer[29] and endometrial 
cancer[30], but not ovarian cancer[31]. In the United States, two case-control studies observed 
consistent strong associations between urine cadmium and breast cancer risk[32, 33].  
This report describes our prospective study of dietary cadmium intake and postmenopausal, 
invasive breast cancer risk in the VItamins And Lifestyle (VITAL) cohort. 
METHODS 
VITAL cohort recruitment (Women) 
Study participants were female members of the VITAL cohort; the details of the study methods 
have been reported previously [34]. Briefly, VITAL was designed to prospectively investigate the 
associations of vitamins, mineral, and specialty supplements with cancer risk. Men and women 
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were eligible to join the cohort if they were aged 50-76 and lived in the 13-county area in 
western Washington State covered by the Surveillance, Epidemiology, and End Results (SEER) 
cancer registry[34]. Because this paper is limited to women, we describe here recruitment of 
women. Using names purchased from a commercial mailing list, we mailed 168,953 baseline 
questionnaires to women, followed by a post-card reminder after 2 weeks. Recruitment was 
conducted from October 2000-December 2002, during which time 41,157 (24.4%) 
questionnaires were returned. Of these, 40,337 passed eligibility and questionnaire quality 
control checks.   
For this analysis we excluded 9 women who were diagnosed after enrollment with rare breast 
cancer histologies (sarcoma, lymphoma, or phyllodes), 1 diagnosed from a death certificate 
only, and 3,160 women with a self-reported history of breast cancer prior to enrollment or 
unknown breast cancer history. An additional 3,948 women were excluded because missing 
food frequency questionnaire responses precluded estimation of dietary cadmium, or because 
they reported <600 kcal or >4000 kcal daily energy intake. Women reporting no periods in the 
year before baseline, had ever used hormone replacement therapy (HRT), reported prior 
bilateral oophorectomy, or were ≥60 years old at baseline were assumed postmenopausal; an 
additional 2,676 pre- and perimenopausal women, and women for whom menopausal status 
was not known were therefore excluded. The final analytical cohort included 30,543 
postmenopausal women. Of these, 26,801 had complete information on all covariates in the 
fully adjusted risk model. Descriptive analysis showed no important differences between 
excluded and included women with respect to smoking or breast cancer risk factors, aside from 
age and menopausal status.  
Data collection 
Data collection was accomplished at baseline using a 24-page self-administered, sex-specific, 
optically scanned questionnaire that covered diet, supplement use, lifestyle, demographics, and 
health history, as detailed previously[34]. 
Diet. Diet was assessed with a food frequency questionnaire (FFQ) that captured usual intakes 
of 120 food, food group, and beverage items over the past one year, and included adjustment 
questions on types of foods and preparation techniques. This was an adaptation of FFQs 
developed for the Women’s Health Initiative and other studies and previously described in detail 
[35-37]. The measurement properties of an earlier version of this questionnaire has been 
published [38].  The FFQ analytic program calculates average annual servings of each FFQ 
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food item, adjusted to sex-specific portion sizes, and estimated nutrient intakes based on the 
Minnesota Nutrient Data System.  
Dietary cadmium. To estimate dietary cadmium intake, we adapted methodology commonly 
used for dietary micronutrient estimates[39]. We relied on cadmium content of foods determined 
by the United States Food and Drug Administration (US FDA) as part of the Total Diet Study 
(TDS), described previously [40, 41]; data are accessible online[42]. Briefly, market baskets of 
285 or 290 foods were typically purchased each year (1991-2008) from three locations in each 
of four regions of the US. These foods were sent to a central laboratory (Lexana, Kansas) for 
preparation according to predetermined recipes, and analysis for content of a number of 
contaminants including cadmium[41]. Cadmium was determined with graphite furnace atomic 
absorption spectroscopy; detection limits depended on the food item and ranged from 0.001 to 
0.007 mg/kg[41].  
Each of 343 food and beverage line items on the VITAL FFQ was matched to one or more foods 
analyzed by US FDA based on the food names provided by US FDA. When FFQ line items 
comprised several foods (e.g., “Muffins, scones, croissants, and biscuits”), we matched each 
component food to the TDS data and combined them using the same weights employed for 
other micronutrient analysis of VITAL data, derived from the design of the FFQ. For 32 foods on 
the FFQ for which no obviously closely similar food was analyzed by US FDA, we relied on food 
mapping created by the US FDA for the TDS[42]. The arithmetic mean of cadmium content (mg 
/ kg prepared weight) reported by US FDA for all samples of each food, 1991-2008, was 
assigned as the cadmium concentration for each food. Reported cadmium levels for food items 
below the limit of detection were assigned values of zero. 
Reproductive history and hormone therapy. Each woman reported her age at menarche, age at 
first birth, and the total number of pregnancies longer than six months. Women were asked 
about use of prescription estrogen and/or progestin as pills or patches, excluding oral 
contraceptives, including years of use by formulation. 
Other variables. Dietary supplements were a focus of the VITAL study and the assessment 
methods have been described in detail[34, 43]. Briefly, supplement use covered the 10 years 
prior to baseline and included use of multivitamins and 16 individual vitamin and mineral 
supplements; assessment was validated with in-depth interviews in a subset of participants[44]. 
For analysis, the nutrient content of multivitamins is based on information from the PDR for Non-
Prescription Drugs [45] and from direct inquiry to manufacturers to determine composition of 
6 
 
multivitamins in the past 10 years. Total intake of iron, zinc, and calcium was calculated by 
summing intake from diet, multivitamins and individual supplements. 
The remaining parts of the questionnaire covered personal identifiers for tracking, demographic 
characteristics, health history, physical activity over the 10 years prior to baseline, cancer 
screening practices, and other potential cancer risk factors. Body mass index (BMI) was 
calculated from self-reported height and weight. Physical activity was assessed with a one-page 
validated questionnaire and converted to metabolic equivalent task hours (MET-h)[46]. To 
assess smoking, women reported whether they had ever smoked cigarettes regularly, defined 
as at least one cigarette per day for at least a year. Those who said yes were asked to report 
the age when they started smoking, the usual number of cigarettes they smoked during the time 
they smoked, the number of years smoked, and whether they smoked currently. Based on this 
information each woman was designated as a never-smoker, current smoker, or former smoker.  
Follow-up for cancer and censoring  
Participants were monitored from date of enrollment to December 31, 2009 for incidence of 
breast cancer. Cases were ascertained by linkage to the western Washington SEER cancer 
registry based on multiple identifying characteristics including name, social security number and 
date of birth as has been described for the VITAL cohort[34]. Tumor estrogen receptor (ER) 
status was retrieved from SEER. During a mean of 7.5 years follow-up, a total of 1,026 incident 
invasive breast cancers were diagnosed in the VITAL cohort and met inclusion criteria for this 
study. Of these, 899 had complete covariate information for adjusted analyses.  
Women not diagnosed with incident invasive breast cancer during follow-up were censored at 
the earliest of the following: incidence of in situ breast cancer (N=273), death (N=1,810), 
withdrawal from the study (N=10), emigration from the SEER registry catchment (N=1,971), or 
December 31, 2009 (N=25,453). Death was ascertained by linkage to the Washington State 
death file, and emigrations were identified through the National Change of Address System and 
active follow-up[34].  
Statistical analyses 
Multivariable Cox proportional hazards regression with age in days as the time variable was 
applied to estimate adjusted breast cancer hazard ratios (aHRs) with 95% confidence intervals 
(95% CIs). Reported P values are two-sided, and P values for linear trend (Ptrend) were 
calculated by modeling dietary cadmium as a continuous variable. Interaction P values are from 
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Wald tests of a multiplicative term added to the fully adjusted model, in which linear continuous 
dietary cadmium was multiplied by the  dichotomous effect modifier variable. Graphical 
inspection of log-log survival plots did not suggest substantial violations of the proportional 
hazards assumption. Additional models in which dietary cadmium as a continuous variable 
interacted with time since study enrollment, or with age, did not show statistically significant 
interactions (P>0.8 in each model for the interaction term). For analyses specific to tumor ER 
status, separate survival analyses were conducted in which women diagnosed with ER+ were 
considered incident cases and ER- cases were censored at time of diagnosis, or vice-versa; 
these analyses result in separate aHRs for ER+ and ER- cancer. To test for the difference in 
association of cadmium with ER+ and ER- tumors, the dataset was reformulated as a case-
control study. Logistic regression was then applied to calculate P values (P-difference) for the 
difference in adjusted odds ratio comparing ER+ cases to ER- cases.  
We selected confounders based on knowledge of breast cancer risk factors, and sources of 
cadmium exposure (e.g., cigarette smoking). Multivariable models were adjusted for age, 
energy intake (kcal, in quartiles), race (white, non-white), education (high school diploma or 
less; some college or post-secondary education; college degree or more), BMI (<18.5 kg/m2, 
18.5-24.9 kg/m2, 25-29.9 kg/m2, ≥30.0 kg/m2), alcohol consumption (continuous, g / d), physical 
activity (continuous, MET-hrs/week), years of combined estrogen plus progesterone HRT, age 
at first birth (nulliparous, ≤19 y, 20-24 y, 25-29 y, ≥30 y), mammography in the two years prior to 
baseline (yes/no), regular multivitamin use (never, former, or current), cigarette smoking history 
(never, former, current), and servings per day of vegetables excluding potatoes. 
RESULTS 
Estimated dietary cadmium intake ranged from 0.5 µg to 55.7 µg per day, with an arithmetic 
mean (standard deviation, SD) of 10.9 (4.9) µg per day. Dietary cadmium intake was higher 
among women who consumed more calories and who ate more servings of vegetables on 
average (Table 1). Women in the highest quartile of estimated dietary cadmium ingestion were 
younger, more highly educated, consumed more alcohol, had higher total energy intake, and 
reported higher physical activity than women in the lower quartiles. Zinc, iron, and calcium 
intake from both dietary and supplementary sources also was higher among women in the 
upper quartiles of dietary cadmium intake, but much of this likely reflects higher  total energy 
intake. Other personal characteristics were not related to dietary cadmium. 
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Vegetables, including potatoes, contributed a mean (± SD) of 44% ± 14% of dietary cadmium. 
Among vegetables, white potatoes contributed an average of 11% ± 8% of total daily dietary 
cadmium, and leafy greens including salads 22% ± 13%. Aside from vegetables, other important 
contributors to dietary cadmium were pasta, breads, grains and cereals including rice (22% ± 
10%). Legumes and beans including peanut and soybean products (4% ± 4%); seafood (3% ± 
2%), fruits (3% ± 3%), and beverages excluding milk (3% ± 3%) were minor sources of dietary 
cadmium. Meats and dairy products (<1%) contributed very little dietary cadmium on average.  
No evidence of an association between dietary cadmium and risk of invasive breast cancer was 
observed, in either age- and energy-adjusted analysis or in analysis further adjusted for 
smoking, vegetable consumption, multivitamin use and certain breast cancer risk factors (Table 
2). This result held for all tumors regardless of estrogen receptor expression (Table 3). No 
evidence of effect modification by cigarette smoking history, HRT use, BMI, multivitamin or 
supplement use, parity, or intake of zinc, iron, or calcium from dietary and supplementary 
sources was found (Table 3). 
DISCUSSION 
Dietary cadmium exposure was not associated with risk of postmenopausal breast cancer in this 
cohort of women residing in the Puget Sound region of Washington State. In addition, no 
interaction of dietary cadmium with breast cancer risk factors, smoking, or intake of calcium, 
zinc, or iron through diet and supplements was observed.  
Occupational exposure to cadmium has been associated with lung cancer, resulting in 
cadmium’s classification as a human carcinogen by the World Health Organization[3]. Non-
occupational exposure to cadmium occurs predominantly through tobacco smoke and food[1], 
and the association between environmental cadmium exposure and risk of various cancers has 
recently received increasing attention. Prospective epidemiological studies have observed 
higher rates of total cancer mortality, and mortality from some specific cancers, associated with 
cadmium exposure, although breast cancer mortality was not associated with cadmium in prior 
studies[27, 28, 47].  
The apparent action of cadmium as an endocrine disruptor or “xeno-estrogen” has stoked 
interest in it as a potential environmental carcinogen, specifically in relation to hormone-driven 
cancers[48]. In contrast to our results, a prospective study of postmenopausal women in the 
Swedish Mammography Cohort  observed increased risk of postmenopausal breast cancer with 
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elevated dietary cadmium[29]; earlier studies in the same Swedish cohort found an association 
of dietary cadmium exposure with endometrial cancer [30] but not ovarian cancer[31]. Like our 
study, these studies combined food frequency questionnaire responses with analytical data from 
a national market-basket survey on the cadmium content of foods. Perhaps consistent with an 
estrogenic mode of action, elevated levels of dietary cadmium were reported to be most strongly 
associated with breast and endometrial cancer risk among women with lower BMI [29, 30].  
Two retrospective case-control studies reported increased risk of breast cancer associated with 
elevated cadmium exposure [32, 33], also in contrast to our results. These studies assessed 
cadmium exposure through measurement of urine cadmium,  an objective marker of cadmium 
absorption over decades, [49, 50], and this methodological difference may explain the 
discrepant results in comparison to our study. However, because of the retrospective design of 
these studies[32, 33], it is also possible that cancer treatment  increased cadmium excretion, 
leading to a non-causal association of urine cadmium with breast cancer. To our knowledge 
there is no extant published data examining how cancer treatments including surgery, radiation, 
and chemotherapy influence urinary heavy metal excretion. Moreover, the modest number of 
cases in each of these studies precluded detailed investigation of potential modification of the 
association between urine cadmium and breast cancer risk, such as smoking, BMI, and diet.  
The large size of the study allowed us to investigate whether the association between cadmium 
and breast cancer risk might differ between subgroups of women defined by personal 
characteristics, and between tumors based on estrogen receptor expression. We focused on 
three areas. First, motivated by the hypothesis that cadmium acts on estrogen signaling 
pathways[48], we examined whether hormone-related breast cancer risk factors including parity, 
BMI, and postmenopausal HRT modified the association between cadmium and breast cancer 
risk. Furthermore, we conducted separate analyses restricted to estrogen-receptor positive or 
negative tumors. We found very little evidence supporting an association of cadmium with 
breast cancer risk in any subgroup examined. Second, we hypothesized that other dietary 
components could modulate uptake of dietary cadmium, or mitigate the carcinogenic potential of 
cadmium. Because cadmium competes with iron, zinc, and calcium for binding sites on cellular 
proteins[51-54], we hypothesized that the cadmium-breast cancer association would be 
strongest among women with low levels of zinc, iron, or calcium intake. We found no evidence 
supporting this notion. More generally, we did not observe evidence that the total amount of 
vegetables consumed mitigated risk of cancer associated with cadmium, in contrast to an earlier 
report from a study of endometrial cancer[30]. Third, cigarette smoking is an important source of 
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cadmium that could mask an effect of dietary cadmium[30, 55, 56]. Therefore we investigated 
whether smoking history acted as a modifier of the dietary cadmium-breast cancer association, 
but found no difference between ever- and never-smokers. 
An important limitation of our study that may partly explain our inability to observe an 
association was our method of exposure assessment. We relied on food frequency 
questionnaire responses of participants to assess the usual intake of foods. These were 
combined with market-basket studies, conducted by the US FDA as part of the Total Diet Study 
[40, 41], that determined the average cadmium content of foods. Thus, our methodology was 
patterned on nutritional epidemiological studies of micronutrients and cancer risk which use a 
food frequency questionnaire.  Such studies are subject to numerous sources of measurement 
error including social desirability bias and poor recall. Specifically, the FFQ we used in this study 
was validated for intake of many micronutrients by comparison to daily food records, and the 
mean correlation between the two methods was ~0.5[38]. This measurement error would be 
non-differential in a prospective cohort study and likely have substantial bias towards a finding 
of no association [57, 58].  
Another possibility is that limited variation in dietary cadmium exposure among the VITAL study 
participants could explain our finding of no association with breast cancer risk. We noted that 
estimated dietary cadmium intake was lower, and exhibited less variation, for VITAL women 
than for women in the Swedish Mammography Cohort studied previously[29, 30]. Although this 
could partly reconcile the results of our study with those of the Swedish Mammography Cohort 
study[29], approximately 12% of all women in the VITAL cohort would have been categorized in 
the upper tertile of dietary cadmium intake in the Swedish Mammography Cohort. Thus, we 
would have expected to observe a trend in breast cancer risk with higher cadmium intake 
comparable to that reported for the Swedish Mammography Cohort, if it existed in our data.  
Our methodology may have introduced misclassification of estimated dietary cadmium from 
multiple sources in addition to problems inherent to FFQs. Our FFQ asked about diet in the year 
prior to enrollment in the VITAL cohort, and therefore responses may not reflect long term 
dietary patterns or exposure to cadmium. Even if FFQ responses accurately capture food 
intake, variation in the cadmium content of food items is likely to be another important sources 
of measurement error, because the amount of cadmium absorbed by crops depends on details 
of growing location and conditions as well as crop varietals[4, 6, 59, 60]. We used the arithmetic 
mean cadmium content of food items measured by US FDA between 1991 and 2008 from cities 
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across the US in our cadmium database. Furthermore, participants in our study resided in 
western Washington State but we used national average values of food cadmium. We chose 
this method because, although we noted that cadmium concentration in relatively cadmium-rich 
individual food items varied several fold between market basket years and locations, we did not 
observe systematic secular trends or regional differences in average cadmium content of foods 
within the data reported by the US FDA, perhaps because many vegetables, and processed or 
packaged foods, are nationally distributed, diminishing regional differences in cadmium content. 
Thus, our estimation of dietary cadmium for an individual reflects the average cadmium content 
of foods across years and geographical locations, rather than the actual cadmium content of 
foods consumed by each participant, as might be measured by urinary assays.  
Our estimates of mean dietary cadmium compare well to previous estimates for US women of 
similar age reported from the US FDA TDS[40]. US FDA employs a sex- and age-specific 
standard diet to routinely estimate dietary intake of hazardous substances including cadmium; 
most recently they estimated 60-65 year old women ingest an average of 9.39 µg cadmium per 
day, 40% of which came from vegetables and 27% from grains[40]. Because we used the food 
cadmium values from the US FDA it is reassuring that when applied to VITAL participant dietary 
data, our average dietary cadmium intake estimate and the relative sources were similar to US 
FDA’s. Estimates of dietary intake of cadmium vary between populations, and with the method 
of diet assessment and with the cadmium database applied. Our estimates are generally 
somewhat lower than estimates from studies based on the (US) National Health and Nutrition 
Examination Survey[61], or in a comparable population of Swedish postmenopausal women[30]. 
We compared the cadmium levels detected in Swedish foods [62-64] with US foods [40-42] but 
could not find systemic differences that might explain different estimates in dietary cadmium 
intake, although comparison was hampered by differences in methodology between Swedish 
and US market basket studies.  
Intake measures from an FFQ may not accurately reflect actual absorbed does of a 
micronutrient or contaminant. Absorption of cadmium from ingested food may vary between 
individuals because of nutritional status. Low circulating ferritin, for example, is associated with 
increased uptake of cadmium from food presumably because cadmium shares transport 
pathways with iron[10, 54, 65]. The bioavailability of cadmium may differ depending on the 
source food or combinations in which foods are eaten[66]; cadmium is bound to chelating 
proteins both in plants[67] and animals[52]. However, we attempted to account for some of 
these variations in absorption by modeling interaction between cadmium intake and intake of 
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calcium, zinc, and iron, as well as total vegetable consumption and multivitamin use. The lack of 
interactions observed suggests that variation in bioavailability and absorption is a relatively 
minor source of variation in our study.  
Although we could not assess occupational exposure to cadmium in the VITAL cohort, a 
previous study of the US adult population suggests that elevated cadmium exposure occurs 
mainly in automotive and electrical repair, mining, metalworking, and similar jobs working 
directly with metals[68]. Because the participants in our study are women over the age of 50 
occupational exposure seems unlikely to be an important in this population. Furthermore, for 
persons without occupational exposure and who have never smoked, dietary intake is the 
largest source of cadmium exposure[5, 61, 69]. Therefore our finding of no association between 
dietary cadmium and breast cancer risk among women with no history of smoking, identical to 
results among all women in the cohort, suggests that unaccounted-for sources of cadmium are 
unlikely to explain our results.     
Finally, because VITAL cohort members were at least 50 years old, the cohort included a small 
proportion of pre- or perimenopausal women, whom we excluded from analysis. Among pre- 
and perimenopausal women, 38 incident breast cancers were observed during the follow up 
period (not shown). Therefore, we were unable to address potential differences between pre- 
and postmenopausal breast cancer and our findings are restricted to postmenopausal breast 
cancer.  
Despite these potential limitations our study has important strengths, including its prospective 
design. We did not observe important systematic differences in estimated cadmium intake 
between VITAL cohort members with complete covariates and those excluded due to 
incomplete data; nor did we find differences in breast cancer risk factors between VITAL 
members with and without complete dietary data used to estimate cadmium intake. Follow-up of 
participants through an established population-based cancer registry and vital statistics 
minimized attrition from the cohort through loss to follow-up. Thus, selection resulting from 
missing data within the cohort, or differential attrition, is unlikely to have biased our results.   
In summary, the results of our study do not support the hypothesis that cadmium contamination 
of food is a risk factor for postmenopausal breast cancer. However, limitations including our 
ability to accurately assess dietary cadmium may have attenuated our estimates of the risk 
associated with cadmium exposure. A more valid assessment of cadmium exposure would be a 
direct measure of cadmium body burden, such as provided by urine cadmium concentration; 
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such an assessment of cadmium exposure could then be tested in relation to breast cancer risk 
in future studies. 
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Table 1. VITAL participant characteristics by quartile of estimated dietary cadmium intake. 
a Based on US FDA Total Diet Study market basket data, 1991-2008. 
b Excluding potatoes. 
c The sum of FFQ items: highly fortified cereals; high fiber or bran cereals; granola; cooked 
cereals and grits; dark breads; and 25% of “rice, noodles, and other grains as side items.” 
 Quartiles of estimated dietary cadmiuma 
 1  2  3  4 
 <7.48 µg/d  7.48-10.05 µg/d  10.06-13.30 µg/d  >13.30 µg/d 
 N=7613  N=7651  N=7621  N=7658 
 Mean SD  Mean SD  Mean SD  Mean SD
Dietary cadmium (µg/d) 5.8 1.2 8.8 0.7 11.6 0.9 17.4 4.3
Age (y) 62.2 7.3 61.8 7.2 61.6 7.2 61.3 7.1
Energy (Kcal)  1021 295 1322 341 1605 400 2021 567
BMI (kg/m2) 27.0 5.7 27.1 5.6 27.3 5.7 27.6 6.1
Physical activity (MET-h/wk) 7.5 10.9 8.6 11.6 9.2 12.1 10.8 13.3
Vegetable consumption (servings/d)b 1.1 0.6 1.8 0.8 2.4 1.1 3.7 1.8
Potatoes (servings/d) 0.17 0.15 0.26 0.21 0.34 0.25 0.43 0.35
Whole grains (servings/d)c 0.45 0.42 0.62 0.52 0.80 0.61 1.05 0.78
Alcohol consumption (g/d) 4.4 10.0 5.2 10.9 5.3 10.0 6.0 11.2
Zinc intake (mg/d) 15.3 11.2 17.7 11.3 19.2 11.1 22.5 11.9
Iron intake (mg/d) 14.9 9.2 17.8 9.0 20.1 9.3 24.4 10.4
Calcium intake (mg/d) 934 582 1099.1 564.4 1219.1 595.6 1428.7 639.6
  
 N %  N %  N %  N %
Cigarette smokingd 
Never 4082 54 4169 54 4219 55 4256 56
Current 830 11 633 8 526 7 428 6
Former 2677 35 2822 37 2847 37 2957 39
Educationd 
Secondary or less 2353 31 1900 25 1631 21 1307 17
Some college 3317 44 3301 43 3117 41 2996 39
College degree 1903 25 2409 31 2832 37 3319 43
Race and ethnicityd 
Non-Hispanic white 7105 93 7182 94 7190 94 7069 92
Other 474 6 435 6 397 5 558 7
Multivitamin use 
Never 2377 31 2135 28 2172 29 2030 27
Former 650 9 655 9 628 8 618 8
Current 4586 60 4861 64 4821 63 5010 65
Age at first childbirth (y)d 
Nulliparous 888 12 938 12 893 12 1033 13
≤19 1603 21 1378 18 1303 17 1174 15
20-24 3256 43 3215 42 3130 41 3034 40
25-29 1335 18 1418 19 1554 20 1603 21
≥30 472 6 634 8 679 9 753 10
HRT use (y)d,e  
Never  4553 60 4347 57 4295 56 4269 56
1-4 949 12 1042 14 1094 14 1124 15
5-9 765 10 890 12 876 11 924 12
≥10 892 12 938 12 929 12 938 12
Mammographyd,f 
No 709 9 597 8 587 8 652 9
Yes 6883 90 7031 92 7014 92 6988 91
15 
 
d Numbers do not sum to total because of missing information. 
e Combined estrogen plus progesterone formulation. 
f Within the two years prior to study baseline. 
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Table 2. Estimated adjusted hazard ratios (aHRs) for invasive breast cancer associated with dietary cadmium intake. 
Dietary cadmium  N  Cases  aHRa (95% CI)a Ptrend  N  Cases  aHRb (95% CI)b Ptrend
Quartile                 
1  7,613  276  Ref    6,576  232 Ref  
2  7,651  248  0.85 (0.71-1.03)   6,691  213 0.91 (0.73-1.15)
3  7,621  258  0.88 (0.72-1.08)   6,718  230 1.03 (0.79-1.35)
4  7,658  244  0.84 (0.67-1.06)   6,816  224 1.00 (0.72-1.41)
                 
per µg/d  30,543  1,026 0.99 (0.97-1.01) 0.29 26,801  899 1.00 (0.98-1.02) 0.95
a Adjusted for age and total energy intake. 
b Adjusted for age, total energy intake, education, race, HRT use (combined estrogen and progesterone), vegetable consumption 
(excluding potatoes), potato consumption, whole grain consumption, cigarette smoking, BMI, physical activity, alcohol consumption, 
age at first childbirth, multivitamin use, and mammography.  
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Table 3. Association of dietary cadmium intake with breast cancer stratified by smoking, breast 
cancer risk factors, total intake of zinc, calcium, and iron, and tumor estrogen receptor 
expression. 
  N Cases aHRa,b (95% CI)b Pinteraction 
Cigarette smoking 
Never  14,787 491 1.01 (0.98-1.04) 
Ever  12,014 408 0.99 (0.96-1.01) 0.07 
HRT usec 
Never  16,121 487 0.99 (0.97-1.02) 
Ever  10,680 412 1.00 (0.98-1.03) 0.44 
BMI (kg/m2) 
<25  10,903 345 1.01 (0.98-1.03) 
≥25  15,898 554 0.99 (0.97-1.02) 0.27 
Parity 
Nulliparous  3,341 128 1.00 (0.97-1.04) 
Parous  23,460 771 1.00 (0.97-1.02) 0.71 
Vegetable consumption (servings/d)d 
<3  20,217 668 1.02 (0.97-1.04) 
≥3  6,584 231 1.00 (0.97-1.02) 0.65 
Regular multivitamin use 
Ever  7,586 272 1.00 (0.97-1.04) 
Never  19,215 627 1.00 (0.97-1.02) 0.82 
Zinc (mg/d)e 
<10.3  6,484 225 1.02 (0.98-1.07) 
≥10.3  20,317 674 1.00 (0.97-1.02) 0.18 
Iron (mg/d)e 
<11.7  6,343 224 1.00 (0.94-1.05) 
≥11.7  20,458 675 1.00 (0.98-1.02) 0.91 
Calcium (mg/d)e 
<706.7  6,516 212 1.00 (0.95-1.04) 
≥706.7  20,285 687 1.00 (0.98-1.02) 0.95 
Tumor estrogen receptor status       P-differencef
ER+  26,801 757 1.00 (0.98-1.03) 
ER-  26,801 123 0.94 (0.89-1.01) 0.11 
a Adjusted for age, total energy intake, education, race, HRT use (combined estrogen and 
progesterone), vegetable consumption (excluding potatoes), potato consumption, whole grain 
consumption, cigarette smoking, BMI, physical activity, alcohol consumption, age at first 
childbirth, multivitamin use, and mammography. 
b per µg cadmium / day. 
c Hormone replacement therapy, combined estrogen and progesterone preparations. 
d Excluding potatoes; cut-off corresponds approximately to lowest quartile among all 
participants. 
e Total intake from diet and multivitamins; cut-offs correspond to lowest quartile among all 
participants. 
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f P-value for difference between ER+ and ER- in association with dietary cadmium, from nested 
case-control analysis. 
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